Bcl-2 blocks apoptotic signal of transforming growth factor-β in human hepatoma cells

Journal of Biomedical Science

Volumn 5, Issue 3, 1998, Pages 185-191

  Huang, Yu Lun ^a   Chou, Chen Kung ^a,b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Antioxidative enzyme; Apoptosis; Bcl 2; Reactive oxygen species; TGF

Indexed keywords

REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; SIGNAL TRANSDUCTION;

EID: 0031810265     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/bf02253468     Document Type: Article

References (66)

1. Akao Y, Otshuki Y, Kataoka S, Ito Y, Tsujimoto Y. Multiple subcellular localization of bcl-2: Detection in nuclear outer membrane, endoplasmic reticulum, and mitochondrial membranes. Cancer Res 54:2468-2471;1994.
2. Allsopp TE, Wyatt S, Paterson HF, Davies AM. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73:295-307;1993.
3. Assoian RK, Komoryia A, Meyers CA, Sporn MB. Transforming growth factor β in human platelets: Identification of a major storage site, purification and characterization. J Biol Chem 258:7155-7160;1983.
4. Boise LH, M Gonzalez-Garcia CE, Postema LD, Lindsten LA, Turka XM, Nuñez G, Thompson C. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic death. Cell 74:597-608;1993.
5. Burow S, Valet G. Flow-cytometric characterization of stimulation, free radical formation, peroxidase activity and phagocytosis of human granulocytes with 2,7-dichlorofluorescein (DCF). Eur J Cell Biol 43:128-133;1987.
6. Charlotte F, L'Hermine A, Martin N, Geleyn Y, Nollet M, Faulard P, Zafrani ES. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 144:460-465;1994
7. Chen RH, Ebner R, Derynck R Inactivation of the type-II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 260:1335-1338;1993.
8. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribo- nucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299;1979.
9. 1 in human hepatoma cells. Anticancer Res 14:147-152;1994.
10. deJong D, Prins FA, Mason DY, Reed JC, van Ommen GB, Kluin PM. Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. Cancer Res 54:256-260;1994.
11. Frolik CA, Dart LL, Meyers CA, Smith DM, Sporn MB. Purification and initial characterization of a type β transforming growth factor from human placenta. Proc Natl Acad Sci USA 80:3676-3680;1983.
12. 1 in the rat hepatoma cell line MCA-RH7777: A possible association with tissue transglutaminase expression. Hepatology 18:945-953;1993.
13. Gajewski TF, Thompson CB. Apoptosis meets signal transduction: Elimination of a Bad influence. Cell 87:589-592;1996.
14. Garcia I, Martinou I, Tsujimoto Y, Martinou JP. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258:302-304;1992.
15. Chen RH, Ebner R, Derynck R. Inactivation of the type-II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 260:1335-1338;1993.
16. Graham F, Van der Eb A. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-457;1973.
17. Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne VL, Culhane AC, Williams GT. Apoptosis: Molecular regulation of cell death. Eur J Biochem 236:1-26;1996.
18. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336;1990.
19. Hockenbergy DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251;1993.
20. Ito N, Kawata S, Tamura S, Takaishi K, Shirai Y, Kiso S, Yabuuchi I, Matsuda Y, Nishooka M, Tarui S. Elevated levels of transforming growth factor β messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res 51:4080-4083;1991.
21. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 262:1274-1277;1993.
22. 1 in rat hepatocytes. J Biol Chem 269:15488-15492;1994.
23. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136;1997.
24. Krajewski S, Tartaka S, Takayama S, Schibler MJ, Fenton W, Reed JC. Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701-4714;1993.
25. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3:614-620;1997.
26. Lechleider RJ, deCaestecker MP, Dehejia A, Polymerapoulos MH, Roberts AB. Characterization of functional domains within Smad4/DPC4. J Biol Chem 272:13690-13696;1997.
27. 1. Cancer Res 52:385-388, 1992.
28. Lithgow T, Van Driel R, Beryram JF, Strasser A. The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the mitochondrial membrane. Cell Growth Differ 5:411-417;1994.
29. Liu F, Hata A, Baker JC, Doody J, Cárcamo J, Harland RM, Massagué JA. Human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381:620-623;1996.
30. Massagué J. Type beta transforming growth factor from feline sarcoma virus-transformed rat cells, isolation and biological properties. J Biol Chem 259:9756-9761;1984.
31. Massagué J. Transforming growth factor β signaling: Receptors, transducers, and Mad proteins. Cell 85:947-950;1996.
32. Masui T, Wakefield LM, Lechner JL, La Veck MA, Sporn MB, Harris CC. Type β transforming growth factor is the primary differentiation-inducing serum factor from normal human bronchial epithelial cells. Proc Natl Acad Sci USA 83:2438-2442;1986.
33. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151-157;1993.
34. Monaghan P, Robertson D, Amos TA, Dyer MJ, Mason DY, Greaves MF. Ultrastructural localization of bcl-2 protein. J Histochem Cytochem 40:1819-1825;1992.
35. Moses HL, Tucker RG, Leof EB, Coffey RJ, Halper J, Shipley GD. Type β transforming growth factor is a growth stimulator and a growth inhibitor. Cancer Cells (Cold Spring Harbor) 3:65-71;1985.
36. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602-3610;1990.
37. Oberhammer F, Bursch W, Parzefall W, Breit P, Erber E, Stadler M, Schulte-Hermann R. Effect of transforming growth factor β on cell death of cultured rat hepatocytes. Cancer Res 51:2478-2485;1991.
38. 1. Proc Natl Acad Sci USA 89:5408-5412;1992.
39. 1 with 5 hours in regressing liver without significant fragmentation of the DNA. Hepatology 18:1238-1246;1993.
40. 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J Cell Biol 126:1079-1088;1994.
41. Oltvai ZN, Millman CL, Korsmeyer SJ. BcI-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619;1993.
42. Park K, Kim SJ, Bang YJ, Park JG, Kim NK, Roberts AB, Sporn MB. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells. Correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 91:8772-8776;1994.
43. Roberts AB, Anzano MA, Meyers CA, Wideman J, Blacher R, Pan T-CE, Stein S, Lehrman SR, Smith JM, Lamb LC, Sporn MB. Purification and properties type β transforming growth factor from bovine kidney. Biochemistry 22:5692-5698;1983.
44. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB. Type β transforming growth factor: A bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 82:119-123;1985.
45. Sánchez A, Álvarez AM, Benito M, Fabregat I. Apoptosis induced by transforming growth factor-β in fetal hepatocyte primary cultures. J Biol Chem 271:7416-7422;1996.
46. 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2572-2576;1995.
47. Servakumaran M, Liebermann DA, Hoffman-Liebermann B. Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: Role in leukemogenesis. Mol Cell Biol 12:2493-2500;1992.
48. Selvakumaran M, Liebermann DA, Hoffman-Liebermann B. Myeloblastic leukemia cells conditionally blocked by myc-estrogen receptor chimeric transgenes for terminal differentiation coupled to growth arrest and apoptosis. Blood 81:2257-2262;1993.
49. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ. bcl-2 inhibits multiple forms of apoptosis but negative selection in thymocytes. Cell 67:879-888;1991.
50. Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K. TAB-1: An activation of the TAK1 MAPKKK in transforming growth factor β signal transduction. Science 272:1179-1182;1996.
51. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JT. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181-184;1989.
52. Sporn MB, Roberts AB, Wakefield LM, deCrombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Ciol 105:1039-1045;1987.
53. Steinman HM. The bcl-2 oncoprotein functions as a pro-oxidant. J Biol Chem 270:3487-3490;1995.
54. 1 in rats and rabbits. Int Rev Exp Pathol 34B:43-67;1994.
55. 1. Am J Physiol 265:L622-L626;1993.
56. Tsujimoto Y. Stress-resistance conferred by high level of bcl-2α protein in human B lymphoblastoid cell. Oncogene 4:1331-1336;1989.
57. Tsujimoto Y. Overexpression of the human Bcl-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proc Natl Acad Sci USA 86:1958-1962;1989.
58. Tu C-PD, Qian B. Human liver glutathione-S-transferase: complete primary sequence of an Ha subunit cDNA. Biochem Biophys Res Commun 141:229-237;1986.
59. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442;1988.
60. Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell 76:777-779;1993.
61. Ventura F, Liu F, Doody J, Massagué J. Interaction of transforming growth factor-β receptor I with farnesyl-protein transferase-α in yeast and mammalian cells. J Biol Chem 271:13931-13934;1996.
62. Walton MI, Whysong D, O'Connor PM, Hockenbery D, Korsmeyer SJ, Kohn KW. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 53:1853-1861;1993.
63. Wang HG, Rapp UR, Reed JC. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629-638;1996.
64. White E. Life, death, and the pursuit of apoptosis. Genes Dev 10:1-15;1996.
65. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. Identification of a member of the MAPKKK family as a potential mediator of transforming growth factor β signal transduction. Science 270:2008-2011;1995.
66. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones PD, Wang X. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275:1129-1132;1197.